Clinical Trials Sponsored by Antaros Medical

Total 55458 results

Sanofi
Antaros Medical

Completed

A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

Sweden
Spago Nanomedical AB
Antaros Medical

Completed

Efficacy of SN132D in Patients With Suspected Endometriosis

Endometriosis

Sweden
Turku University Hospital
Antaros Medical

Completed

A Repeatability Study of Fatty Acid Uptake Using PET/MR Imaging in Patients With T2DM and Non-diabetic Control Subjects (AM05)

Diabetes Mellitus, Type 2

Finland
Stayble Therapeutics
Cromsource; Antaros Medical; VIEDOC

Recruiting

STA363 in the Treatment of Lumbar Disc Herniation

Lumbar Disc Herniation

Poland
Cambridge University Hospitals NHS Foundation Trust
Antaros Medical

Recruiting

Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes (COCONUT)

Obesity | Type 2 Diabetes

United Kingdom
Antares Pharma Inc.

Completed

Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism

Hypogonadism

United States
Antares Pharma Inc.

Completed

Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism (STEADY)

Hypogonadism

United States
Antares Pharma Inc.

Completed

Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence

Urinary Frequency | Urge Urinary Incontinence

United States
Antares Pharma Inc.

Completed

Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device

Rheumatoid Arthritis (RA)

United States
Antares Pharma Inc.

Completed

Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism

Hypogonadism

United States
Antares Pharma Inc.

Completed

Pharmacokinetic Study of Testosterone Enanthate

Hypogonadism

United States
Antares Pharma Inc.

Completed

Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device

Rheumatoid Arthritis (RA)

United States
Antares Pharma Inc.

Completed

Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration

Rheumatoid Arthritis

United States
AstraZeneca
Antaros Medical; Bioventure Hub; 43183 Mölndal; Sweden

Completed

Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus (DERISC)

Type 2 Diabetes Mellitus

Finland
Antares Pharma Inc.

Completed

Pharmacokinetic Study of Subcutaneous Testosterone Enanthate

Hypogonadism

United States
Spago Nanomedical AB
CTC Clinical Trial Consultants AB; Antaros Medical

Completed

A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer (SPAGOPIX-01)

Breast Cancer | Pancreas Cancer

Sweden
Anterios Inc.

Completed

Dose Finding Study In Subjects With Crow's Feet

Lateral Canthal Lines | Crow's Feet

United States
Anterios Inc.

Completed

Clinical Trial To Evaluate ANT-1207 In Subjects With Acne

Acne Vulgaris

United States
Anterios Inc.

Completed

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

Lateral Canthal Lines | Crow's Feet

United States
Syneos Health
Antares Pharma Inc.

Withdrawn

Phase 1 Study of ATRS-2002 in Healthy Male Adults

Metastatic Castration-resistant Prostate Cancer
Anterios Inc.

Completed

Clinical Trial to Evaluate ANT-1401 in Crow's Feet

Lateral Canthal Lines | Crows Feet

United States
Anterios Inc.

Completed

Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

United States
Anteris Technologies Ltd.

Active, not recruiting

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study (DurAVR™ EFS)

Aortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic Stenosis

United States
Anteris Technologies Ltd.

Active, not recruiting

DurAVR™ THV System: First-In-Human Study

Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic Stenosis

Georgia
Antios Therapeutics, Inc

Terminated

A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection

Hepatitis D | Hepatitis B, Chronic

Moldova, Republic of, Ukraine
Antios Therapeutics, Inc

Completed

A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects

Drug Drug Interaction

Canada
Antios Therapeutics, Inc

Terminated

Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects

Chronic Hepatitis b

United States
Antios Therapeutics, Inc

Terminated

A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection

Chronic Hepatitis b

Moldova, Republic of, Ukraine
Antios Therapeutics, Inc

Completed

A Drug-Drug Interaction Study Between ATI-2173 and Tenofovir Disoproxil Fumarate in Healthy Subjects

Drug Interaction

Canada
Antios Therapeutics, Inc

Completed

A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

Hepatitis B, Chronic

Canada, Moldova, Republic of, Ukraine
Santaris Pharma A/S

Completed

Multiple Ascending Dose Study of SPC4955 in Healthy Subjects

Hypercholesterolemia

Germany
Santaris Pharma A/S

Completed

Safety Study of SPC3649 in Healthy Men

Hepatitis C

Denmark
Santaris Pharma A/S

Unknown

Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

Hepatitis C

Puerto Rico
Santaris Pharma A/S

Completed

SPC3649 Multiple Dose Study in Healthy Volunteers

Hepatitis C

Netherlands
Vilnius University
Vilnius University Hospital Santaros Klinikos

Recruiting

HYPoxaEmic Respiratory Failure and Awake Prone Ventilation (Hyper-AP)

Respiratory Failure | Hypoxemia

Lithuania, United Kingdom
Vilnius University
Vilnius University Hospital Santaros Klinikos

Recruiting

Impact of Patient Education on Preoperative Anxiety and Postoperative Psychosocial Outcomes

Preoperative Anxiety

Lithuania
Anthos Therapeutics, Inc.

Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) (LILAC-TIMI 76)

Atrial Fibrillation (AF)

United States, Canada, Israel, Japan, China, Brazil, Chile, United Kingdom, Bulgaria, Germany, Hungary, Italy, Poland, Romania, Spain, Czechia, Latvia, Mexico
Santaris Pharma A/S

Unknown

Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection

Hepatitis C, Chronic

Puerto Rico, United States
Santaris Pharma A/S

Completed

Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects

Hepatitis C | Chronic Hepatitis C

United States
Santaris Pharma A/S

Completed

Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects

Hepatitis C

United States, Germany, Netherlands, Poland, Puerto Rico, Slovakia
Santaris Pharma A/S

Terminated

Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH

Hypercholesterolemia

Netherlands
Santaris Pharma A/S

Completed

SPC2996 in Chronic Lymphocytic Leukaemia

Chronic Lymphocytic Leukemia

France, Denmark, United Kingdom, United States
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, Spain, Japan, Canada, Ireland, Italy, Korea, Republic of, France, Switzerland, Hungary, Netherlands, Latvia, Germany, Norway, Sweden, Czechia, United Kingdom
Andros Day Surgery Clinic

Completed

Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response

Ovarian Response

Italy
Anthos Therapeutics, Inc.
Covance

Completed

A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation

Atrial Fibrillation

United States
Andros Day Surgery Clinic

Terminated

Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles

In Vitro Fertilization | Ovarian Stimulation

Italy
Vilnius University
Vilnius University Hospital Santaros Klinikos

Recruiting

A Comparative Prospective Study of the Arthroscopic Meniscus Repair Methods

Meniscus Tear Caused by a Traumatic Event

Lithuania
Vilnius University Hospital Santaros Klinikos
Vilnius University

Completed

Comparison of Percutaneous Coronary Intervention Optimization With Fractional Flow Reserve Versus Intravascular Ultrasound in the Treatment of Long Coronary Artery Lesions

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease
Vilnius University Hospital Santaros Klinikos
Vilnius University

Completed

The Implementation of Intravascular Ultrasound and Fractional Flow Reserve in the Percutaneous Treatment of Very Long Coronary Artery Lesions

Coronary Artery Disease

Lithuania
Andros Day Surgery Clinic

Terminated

Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles

Infertility | In Vitro Fertilization

Italy

Clinical Trials Sponsored by Antaros Medical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations